Cover Image

Recent Advances in the Discovery of SIRT1/2 Inhibitors via Computational Methods: A Perspective

Sirtuins (SIRTs) are classified as class III histone deacetylases (HDACs), a family of enzymes that catalyze the removal of acetyl groups from the ε-N-acetyl lysine residues of histone proteins, thus counteracting the activity performed by histone acetyltransferares (HATs). Based on their involvemen...

Full description

Saved in:

Bibliographic Details
Main Authors:	Naomi Scarano (Author), Chiara Brullo (Author), Francesca Musumeci (Author), Enrico Millo (Author), Santina Bruzzone (Author), Silvia Schenone (Author), Elena Cichero (Author)
Format:	Book
Published:	MDPI AG, 2024-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Novel Thiazole-Based SIRT2 Inhibitors Discovered via Molecular Modelling Studies and Enzymatic Assays
by: Elena Abbotto, et al.
Published: (2023)

Probing Allosteric Hsp70 Inhibitors by Molecular Modelling Studies to Expedite the Development of Novel Combined F508del CFTR Modulators
by: Roberto Sabbadini, et al.
Published: (2021)

Unlocking Potential and Limits of Kinase Inhibitors: The Highway to Enhanced Cancer Targeted Therapy
by: Francesca Musumeci, et al.
Published: (2024)

Recent advance in the discovery of tyrosinase inhibitors from natural sources via separation methods
by: Xiao-wei Zhang, et al.
Published: (2021)

In Silico and In Vitro Evaluation of the Mechanism of Action of Three VX809-Based Hybrid Derivatives as Correctors of the F508del CFTR Protein
by: Debora Baroni, et al.
Published: (2023)

Computational Design and Optimization of Peptide Inhibitors for SIRT2
by: Heba A. Alkhatabi, et al.
Published: (2024)

New Insights into the LANCL2-<b>ABA</b> Binding Mode towards the Evaluation of New LANCL Agonists
by: Naomi Scarano, et al.
Published: (2023)

SIRT2i_Predictor: A Machine Learning-Based Tool to Facilitate the Discovery of Novel SIRT2 Inhibitors
by: Nemanja Djokovic, et al.
Published: (2023)

Discovery of a potent and highly selective inhibitor of SIRT6 against pancreatic cancer metastasis in vivo
by: Xinyuan Xu, et al.
Published: (2024)

Sweet Cherry Extract as Permeation Enhancer of Tyrosine Kinase Inhibitors: A Promising Prospective for Future Oral Anticancer Therapies
by: Federica Poggialini, et al.
Published: (2023)

Recent Advances in Covalent Drug Discovery
by: Daniel Schaefer, et al.
Published: (2023)

Identification of NAPRT Inhibitors with Anti-Cancer Properties by In Silico Drug Discovery
by: Moustafa S. Ghanem, et al.
Published: (2022)

Computational Drug Repurposing for Antituberculosis Therapy: Discovery of Multi-Strain Inhibitors
by: Valeria V. Kleandrova, et al.
Published: (2021)

Advances in the discovery of exosome inhibitors in cancer
by: Huarui Zhang, et al.
Published: (2020)

Recent advances in combinatorial biosynthesis for drug discovery
by: Sun H, et al.
Published: (2015)

Discovery and characterization of a new class of NAD+-independent SIRT1 activators
by: Sara Della Torre, et al.
Published: (2024)

Discovery of potential WEE1 inhibitors via hybrid virtual screening
by: Tingting Jin, et al.
Published: (2023)

Discovery of new butyrylcholinesterase inhibitors via structure-based virtual screening
by: Noor Atatreh, et al.
Published: (2019)

Sirt1 and Sirt3 Activation Improved Cardiac Function of Diabetic Rats via Modulation of Mitochondrial Function
by: Bugga Paramesha, et al.
Published: (2021)

Iminosugar-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors as Potential Anti-Pancreatic Cancer Agents
by: Irene Conforti, et al.
Published: (2023)

Recent Advances in Machine Learning and Computational Intelligence
Published: (2023)

Recent Advances in Brain-Computer Interface Systems
Published: (2011)

Recent Advances in Embedded Computing, Intelligence and Applications
Published: (2022)

New Pyrazolyl Thioureas Active against the <i>Staphylococcus</i> Genus
by: Anna Maria Schito, et al.
Published: (2024)

The discovery of novel HDAC3 inhibitors via virtual screening and in vitro bioassay
by: Jie Xia, et al.
Published: (2018)

Discovery of MurA Inhibitors as Novel Antimicrobials through an Integrated Computational and Experimental Approach
by: Fangyuan Zhang, et al.
Published: (2022)

Discovery of human coronaviruses pan-papain-like protease inhibitors using computational approaches
by: Mubarak A. Alamri, et al.
Published: (2020)

New Insights into the Binding Features of F508del CFTR Potentiators: A Molecular Docking, Pharmacophore Mapping and QSAR Analysis Approach
by: Giada Righetti, et al.
Published: (2020)

Recent Advances in Mitochondrial Pyruvate Carrier Inhibitors
by: Yilei Huang, et al.
Published: (2024)

Advances in the discovery of cathepsin K inhibitors on bone resorption
by: Jun Lu, et al.
Published: (2018)

Recent Discoveries in Evolutionary and Genomic Microbiology
by: Anton G. Kutikhin
Published: (2015)

Structure-guided discovery of novel dUTPase inhibitors with anti-Nocardia activity by computational design
by: Zhi-Zheng Wang, et al.
Published: (2024)

Recent progress in discovery of novel AAK1 inhibitors: from pain therapy to potential anti-viral agents
by: Ying-Hui Yuan, et al.
Published: (2023)

Recent advances in JAK inhibitors for the treatment of metabolic syndrome
by: Debora Collotta, et al.
Published: (2023)

Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development
by: Yurong Lai, et al.
Published: (2022)

Recent Advances in Peptide Drug Discovery: Novel Strategies and Targeted Protein Degradation
by: Katarina Vrbnjak, et al.
Published: (2024)

Targeted Covalent Inhibitors in Drug Discovery, Chemical Biology and Beyond
by: Ricardo A. M. Serafim, et al.
Published: (2024)

Computational Drug Discovery in Patients with Endometriosis-Induced Infertility via Text Mining and Biomedical Databases
by: Yingying Lin, et al.
Published: (2022)

Amino Acid Biosynthesis Inhibitors in Tuberculosis Drug Discovery
by: Michela Guida, et al.
Published: (2024)

The Anticancer Effect of a Flavonoid-Rich Extract of Bergamot Juice in THP-1 Cells Engages the SIRT2/AKT/p53 Pathway
by: Alessandro Maugeri, et al.
Published: (2022)